Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy

OBJECTIVE: The main goal of this work was to identify, describe, characterize, and classify the scientific evidence regarding the use of pharmacogenomic biomarkers in antidepressant treatment. METHODS: The work was developed in two phases: i) a search for pharmacogenomic biomarkers in summaries of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Correia, Catarina, Alcobia, Luciano, Lopes, Manuel José, Advinha, Ana Margarida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425945/
https://www.ncbi.nlm.nih.gov/pubmed/36042420
http://dx.doi.org/10.1186/s12888-022-04225-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425945/
https://www.ncbi.nlm.nih.gov/pubmed/36042420
http://dx.doi.org/10.1186/s12888-022-04225-2

Ejemplares similares